Log In
BCIQ
Print this Print this
 

MoxDuo CR (Q8011CR)

  Manage Alerts
Collapse Summary General Information
Company QRxPharma Ltd.
DescriptionControlled-release formulation of oxycodone and morphine
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor agonist
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat moderate to severe pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today